INTERCEPT Plasma: Abstracts

2010 ABSTRACTS

XXXIst International Congress of the International Society of Blood Transfusion (ISBT)
June 26 - 1, 2010 | Berlin, Germany

1. N De Valensart, A Rapaille, R Meuter et al. Plasma from Whole Blood Treated with INTERCEPT Platelet Processing Set. Vox Sanguinis 2010;99 (Suppl. 1), 240
   [Poster PDF]
   
   
2. Sandrine Massard, Corinne Civadier, Anne Sailliol et al. Routine Production of Apheresis Plasma Pathogen Inactivated Using the INTERCEPT Blood System™: Preservation of Plasma Quality. Vox Sanguinis 2010;99 (Suppl. 1), 258
   [Poster PDF]
   
   
3. AL Pajares Herraiz, AP Rodriguez, VI Diaz et al. Modification of the INTERCEPT Processing Set for Plasma: Easier and Faster Pathogen Inactivation. Vox Sanguinis 2010;99 (Suppl. 1), 242
   
   
4. Wilfried Saldado, Françoise Le Yondre, Marie-Paule Perrault et al. Process Validation of the INTERCEPT Blood System™ for Pathogen Inactivation of Apheresis Plasma at a Regional Center (EFS-Centre Atlantique). Vox Sanguinis 2010;99 (Suppl. 1), 254
   
   
5. Olivier Garraud, Patricia Chavarin, Céline de Putter et al. Validation of the INTERCEPT Blood System™ for Pathogen Inactivation of Apheresis Plasma at a Regional Center (EFS-Auvergne Loire).
   Vox Sanguinis 2010;99 (Suppl. 1), 253
   [Poster PDF]
   
   
6. Michael Müller-Steinhardt, Karin Janetzko. Evaluation of Apheresis Plasma Treated with INTERCEPT™ Pathogen Inactivation. Vox Sanguinis 2010;99 (Suppl. 1), 251
   
   
7. Christina Lehmann, Silke Rummler, Christel Kummer et al. Pathogen Inactivation Of Single Donor Plasma. Vox Sanguinis 2010;99 (Suppl. 1), 242
   
   
   

12th International Haemovigilance Seminar
February 17 - 19, 2010 | Dubrovnik, Croatia
[back to top]

1. JP Cazenave, JC Osselaer, W Liu, A Elliot, W Reed, L Lin, L Corash. An Active Hemovigilance Program to Assess the Safety Outcome for 32, 480 INTERCEPT Plasma Component Transfusions.
   [Poster PDF]
   
   
2. D Kientz, I Mendel, C Waller, H Isola, JP Cazenave. Hemovigilance Surveillance Of Therapeutic Plasma Prepared With Pathogen Inactivation Treatment During a Two Year Period.
   [Poster PDF]

2009 ABSTRACTS

2009 AABB Annual Meeting & TXPO
October 24 - 27, 2009 | New Orleans, USA
[back to top]

1. H Isola, D Kientz, F Bigey, S Somme, C Forny, J Cazenave. The Impact of Replacing Quarantine Plasma by Plasma Prepared with Pathogen Inactivation (INTERCEPT™) – Experience in EFS-Alsace. Transfusion 2009; 49(suppl 1):81A
   [Poster PDF]
   

42nd Annual Congress of the German Society for Transfusion Medicine and Immunohaematology (DGTI)
September 15 - 18, 2009 | Rostock, Germany
[back to top]

1. C Lehmann, S Rummler, C Kummer, D Barz. A New Cell Free, Pathogen Inactivated Single Donor Plasma. Transfus Med Hemother 2009;36(suppl 1):1-62
   

24th Société Français de Transfusion Sanguine (SFTS)
June 22 - 25 | Strasbourg, France

1. S Massard, C Civadier, I Ernou, S Dhuguet, A Sanchez, C Antoinette, M Slaedts, M Joussemet. Mise en place du procede INTERCEPT sure le plasma au CTSA.

Congreso Nacional de la Sociedad Espanola de Transfusion Sanguinea (SETS)
June 11 - 13 | Tarragona, Spain
[back to top]

1. A Pajares, L Barea, P Rodriguez, F Surribas , I Diaz, L Lopez, E Castro. Mejora en la eficiencia del sistema INTERCEPT para plasma mediante un dispositivo para mezclar 5 PFC.

14th Annual Congress of the European Hematology Association (EHA)
June 4 - 7, 2009 | Berlin, Germany
[back to top]

1. JP Cazenave, I Mendel, C Waller, JC Osselaer, M Jacquet, M Propst, L Lin, L Corash, D Kientz. Active Hemovigilance of Pediatric Patients Supported with Plasma Components Prepared with Amotosalen Plus UVA Photochemical Treatment.
   [Poster PDF]
   
   
2. D Kientz, ML Wiesel, I Lanois, T Krummel, B Moulin, R Herbrecht, JP Cazenave. Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic Uremic Syndrome (HUS) Using Plasma Prepared with Photochemical Pathogen Inactivation: A One Year Experience in Routine Practice in a Regional Blood Center.
   [Poster PDF]

XIXth Regional Congress International Society of Blood Transfusion (ISBT)
March 21 – 25, 2009 | Cairo, Egypt
[back to top]

1. JP Cazenave, JC Osselaer, C Waller, M Jacquet, L Lin, L Corash, and D Sundin. An Active Hemovigilance Program Utilizing an EDC System to Assess Safety of 6359 Plasma Component Transfusions Prepared with the INTERCEPT Blood System. Vox Sanguin 2009;96(Suppl 1):208-209.
   [Poster PDF]
   
   
2. E Castro, AL Pajares, LM Barea, P Rodriguez, F Surribas, P Simon, P Carmichael and L Lin. A New Tool for Increasing the Efficiency of INTERCEPT Pathogen Inactivation (PI) System for Plasma. Vox Sanguin 2009;96(Suppl 1):220-221.
   [Poster PDF]
   
   
3. L Pinkoski and L Corash. INTERCEPT Plasma Retains Coagulation Factor Activity when Prepared from Different Plasma Sources.Vox Sanguin 2009;96(Suppl 1):231-232.
   [Poster PDF]
   
   
4. L Sawyer, S Higgs, K Tsetsarkin, D Vanlandingham, R Johnson. Inactivation of Transfusion-Transmitted Vector Borne Pathogens. Vox Sanquin 2009;96(Suppl 1):233-234.
   [Poster PDF]

2008 ABSTRACTS

Jump to conference:
December - ASH
October - AABB
September - DGTI
June - ISBT
May - SETS

50th American Society of Hematology Meeting & Exposition (ASH)
December 6 - 9, 2008 | San Francisco, USA
[back to top]

1. JP Cazenave, P Ohlmann, H Isola, C Gachet. Photochemical Pathogen Inactivation Treatment of Human Plasma (amotosalen + UVA) Has No Major Impact on the Protein expression pattern Assessed by a 2-DIGE Proteomic Assay. Blood 2008;112(11):696
   View abstract >

American Association of Blood Banks Annual Meeting & TXPO (AABB)
October 4-7, 2008 | Montréal, Canada
[back to top]

1. JP Cazenave, J Osselaer, C Waller, M Jacquet, L Lin, L Corash, et al. An Active Hemovigilance Program Utilizing an EDC System to Assess Safety of 2994 Plasma Transfusions Prepared with the INTERCEPT Blood System. Transfusion 2008;48 (S1);29A
   
   
2. K Dupuis, A Sampson-Johannes, J Kinsey et al. Inactivation of Influenza A H5N1 and Lymphocytic Choriomeningitis Virus (LCMV) by the INTERCEPT Blood System (IBS).Transfusion 2008;48 (S1);88A
   
   
3. N De Valensart, A Rapaille, E Goossenaerts et al. INTERCEPT Pathogen Inactivation for Plasma: Preservation of Coagulation Factors and Ease of Implementation.
   Transfusion 2008;48 (S1);145A
   [Poster PDF]
   

Joint Annual Congress of the Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI)
September 16 - 19, 2008 | Düsseldorf, Germany
[back to top]

1. JP Cazenave, H Isola, L Pinkoski, L Corash. Coagulation Factor Activity in Whole Blood-Derived Plasma Treated with the INTERCEPT Blood System 18 Hours after Collection. Transfus Med Hemother 2008;35(suppl 1):60
   

XXXth International Congress of the International Society of Blood Transfusion (ISBT)
June 7–12, 2008 | Macao, China
[back to top]

1. M Steiert, E Castro, P Grellier, J Benach, WC Van Voorhis, RT Eastman, K Dupuis, L Sawyer, L Lin. Photochemical Inactivation with Amotosalen and UVA Light of Protozoan Parasites in Platelet and Plasma Components Using INTERCEPT Blood System.
   Vox Sang 2008;95(Suppl 1):291
2. K Dupuis and L Sawyer. Inactivation of Influenza Virus Type A H5N1 in Platelets and Plasma by Treatment with the INTERCEPT Blood System.
   Vox Sang 2008;95(Suppl 1):301
3. F Knutson, K Lejskog, M Ståhle, O Korsgren. The INTERCEPT Technology as Novel Approach for the Generation of Pathogen Inactivated Serum for the Culturing of Pancreatic Islets: Opportunities for Improvements.
   Vox Sang 2008;95(Suppl 1):279
4. L Pinkoski, T Peterson, J Bayat, L Corash. Coagulation Factor Activity In INTERCEPT Plasma after Storage for 24 Months at -25° C.
   Vox Sang 2008;95(Suppl 1):288
5. A Rapaille, N de Valensart, E Goossenaerts, J Irsch, L Lin, V Deneys. INTERCEPT Treatment for Pathogen Inactivation of Thawed Plasma: Coagulation Factors and Function are Preserved.
   Vox Sang 2008;95(Suppl 1):292
6. N de Valensart, A Rapaille, E Goossenaerts, J Irsch, L Lin, V Deneys. Analysis of the Impact of INTERCEPT Treatment on Fresh Plasma: Preservation of Coagulation Factors and Inhibitors Functional Activity.
   Vox Sang 2008;95(Suppl 1):293
7. JC Osselaer, L Defoin, M Goffaux, M Vandendaele, L Lin, E Goossenaerts, P Carmichael. Routine Production of Three Plasma Products from One INTERCEPT Blood System Treatment.
   Vox Sang 2008;95(Suppl 1):294
8. JP Cazenave, JC Osselaer, C Waller, M Jacquet, L Lin, L Corash, and D Sundin. Results from an Ongoing Hemovigilance Program Using an Electronic Data Capture System to Characterize the Safety Profile of Plasma Transfusions Prepared with the INTERCEPT Blood System.
   Vox Sang 2008;95(Suppl 1):296
9. JP Cazenave, P Netzer, C Ravanat, A Boucher, H Isola, D Kientz, C Gachet, ML Wiesel. Thrombin Generation Capacity of Therapeutic Apheresis Plasma is Maintained Following Pathogen Inactivation with Photochemical Treatment (INTERCEPT Blood System).
   Vox Sang 2008;95(Suppl 1):306
10. H Isola, D Kientz, F Bigey, C Waller, M Laforet, ML Wiesel, JP Cazenave. Implementation of Pathogen Inactivated Therapeutic Apheresis Plasma Following Photochemical Treatment with INTERCEPT by EFS-Alsace, a French Regional Blood Center.
    Vox Sang 2008;95(Suppl 1):306-307
11. M Naegelen, H Isola, P Morel, JP Cazenave. Impact on Organization of Production of Inactivated Therapeutic Plasma with Two Photochemical Treatments, Methylene Blue or Amotosalen, in Two French Regional Blood Centers.
    Vox Sang 2008;95(Suppl 1):30

Congreso Nacional de la Sociedad Espanola de Transfusion Sanguinea (SETS)
May 29 - 31, 2008 | Cadiz, Spain
[back to top]

1. JP Cazenave, JC Osselaer, C Waller, M Jacquet, L Lin, L Corash, and D Sundin. Results from an Ongoing Hemovigilance Program Characterizing the Safety Profile of Plasma Transfusions Prepared With Photochemical Treatment (INTERCEPT Blood System)
   

2007 ABSTRACTS

Jump to conference:
December - ASH
October - AABB
June - ISBT

The American Society of Hematology 49th Annual Meeting and Exposition (ASH)
December 8 –11, 2007 | Atlanta, Georgia
[back to top]

1. JP Cazenave, P Netzer, S Schuhler, C Ravanat, H Isola, D Kientz, C Gachet, ML Wiesel. Retention of Thrombin Generation Capacity of Therapeutic Apheresis Plasma Prepared with Amotosalen and UVA Light (INTERCEPT) Pathogen Inactivation. Blood 2007;110(11):75

American Association of Blood Banks Annual Meeting and TXPO (AABB)
October 20 –23, 2007 | Anaheim, California, USA
[back to top]

1. L Pinkoski, L Corash. Complement Factors H and I Are Conserved in Plasma After Pathogen Inactivation With Amotosalen and UVA Light. Transfusion 2007;47 (S3):72A

XVIIth Regional Congress of the International Society for Blood Transfusion (ISBT)
June 24-27, 2007 | Madrid, Spain
[back to top]

1. JC Osselaer, C Debry, M Goffaux, E Dubuc, B Chatelain, MC Vandendaele. Coagulation Function in Fresh Frozen Plasma Prepared with Two Photochemical Treatment Methods.
   [Poster PDF]
2. E Castro, JL Bueno, M Díaz-Ricart, M Palomo, G Escolar. The Effect of Photochemical Treatment (PCT) with Amotosalen and UVA Light on Coagulation Function of Concurrent Plasma from Platelet Apheresis.
   [Poster PDF]
3. J Cid, O Magallon, M Claparols, A Pinacho, P Ortiz, L Puig, RP Pla. Levels Of Coagulation Factors in Fresh Frozen Plasma Obtained from Whole Blood Donations and Prepared with Two Photochemical Treatment Methods

2006 ABSTRACTS

Jump to conference:
December - ASH
October - AABB
September - ISBT
March - ICEID

The American Society of Hematology 48th Annual Meeting and Exposition (ASH)
December 9 – 12, 2006 | Orlando, Florida, USA
[back to top]

1. Jean-Pierre Cazenave, Hervé Isola, Marie-Louise Wiesel, Daniel Kientz, Michel Laforêt, Marc Slaedts, Linda Pinkoski, Yasmin Singh and Laurence Corash. Coagulation Factors In Therapeutic Apheresis Plasma Held For 18 Hours At Ambient Temperature Prior To Pathogen Inactivation (INTERCEPT™).
   [Poster PDF]
2. Jean-Pierre Cazenave, Hervé Isola, Marie-Louise Wiesel, Daniel Kientz, Michel Laforêt, Linda Pinkoski, Yasmin Singh and Laurence Corash. Coagulation Factor Activity In Therapeutic Plasma Prepared From Whole Blood With Pathogen Inactivation (INTERCEPT™) Treatment.
   
3. Markus M. Mueller, Hans-Ulrich Pfeiffer, Margaret Rheinschmidt, Bernd Poetzsch, Johannes Oldenburg, Laurence Corash, Erhard Seifried and Reinhard Henschler. Effects of Pathogen Inactivation Using Amotosalen on Coagulation Parameters in Apheresis and Whole Blood Derived Fresh Frozen Plasma in a Large Blood Bank Setting.
   

American Association of Blood Banks Annual Meeting & TXPO (AABB)
October 21-24, 2006 | Miami Beach, FL
[back to top]

1. L. Pinkoski, T. Peterson, Y. Singh, L. Corash. Coagulation Factor Activity in Photochemically Treated Plasma Prepared From Previously Frozen Plasma.
   [Poster PDF]
2. L. Pinkoski, T. Peterson, Y. Singh, L. Corash. Coagulation Factor Activity in Photochemically Treated Plasma After Storage at 18ºC or –25ºC.
   [Poster PDF]
3. Sawyer L, Hsu J, Bernard K, Sampson-Johannes A, Dupuis K, Pinna D, Lane R, Grellier P, Van Voorhis W, Benach J, Lin L. Inactivation of Emergent Blood-borne Pathogens in Plasma and Platelets.
   [Poster PDF]

International Society for Blood Transfusion (ISBT)
September 2-7 2006 | Cape Town, South Africa
[back to top]

1. JP Cazenave, H Isola, M-L Wiesel, D Kientz, M Laforêt, V Mayaudon, L Pinkoski, Y Singh, L Corash. Stability of Coagulation Factors in Plasma Prepared with Photochemical Treatment (INTERCEPT) Stored for One Year.
   [Poster PDF]
2. JC Osselaer, C Debry, M Goffaux, E Dubuc, B Chatelain, M Rheinschmidt, L Lin. Coagulation Function in Fresh Frozen Plasma Prepared with Two Photochemical Treatment Methods
   [Poster PDF]
3. L Corash, N Bass, L Petz, R Steadman, M Streiff, J McCullough, P Mintz. Fresh Frozen Plasma for Management of Hemostasis During Minor and Major Surgical Procedures Associated With Coagulopathy.
   [Poster PDF]
4. L Pinkoski, T Peterson, J Bayat, H Evans, Y Singh, L Corash. Coagulation Factor Activity in 180 mL and 325 mL Units of Photochemically Treated Plasma (INTERCEPT Plasma) After Storage for 12 Months at -18ºC.
   [Poster PDF]
5. L Sawyer, K. Dupuis, A. Sampson-Johannes, T. Dubensky, D.L. Vanlandingham, K. Tsetsarkin S. Higgs. Inactivation of Chikungunya Virus in Plasma and Platelets Using Helinx Technology, as Utilized in the INTERCEPT Blood System
   [Poster PDF]

International Conference on Emerging Infectious Diseases (ICEID)
March 19-22, 2006 | Atlanta, Georgia
[back to top]

1. L Sawyer, J Benach, K Bernard, K Dupuis, P Grellier, JC Hsu, R Lane, L Lin, A Sampson-Johannes, W van Voorhis, E Vicenzi.  Inactivation of Emergent Blood-borne Pathogens in Plasma and Platelets Using the INTERCEPT Blood System.
   [Poster PDF]